OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
Talia Greenstein, Bree B. Aldridge
Frontiers in Cellular and Infection Microbiology (2023) Vol. 12
Open Access | Times Cited: 8
Talia Greenstein, Bree B. Aldridge
Frontiers in Cellular and Infection Microbiology (2023) Vol. 12
Open Access | Times Cited: 8
Showing 8 citing articles:
How macrophage heterogeneity affects tuberculosis disease and therapy
David G. Russell, Nelson V. Simwela, Joshua T. Mattila, et al.
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 4
David G. Russell, Nelson V. Simwela, Joshua T. Mattila, et al.
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 4
Small-Molecule Antibiotic Drug Development: Need and Challenges
Megan Bergkessel, Barbara Forte, Ian H. Gilbert
ACS Infectious Diseases (2023) Vol. 9, Iss. 11, pp. 2062-2071
Open Access | Times Cited: 30
Megan Bergkessel, Barbara Forte, Ian H. Gilbert
ACS Infectious Diseases (2023) Vol. 9, Iss. 11, pp. 2062-2071
Open Access | Times Cited: 30
Revolutionizing Fixed-Dose Combinations with Long-Acting Microsphere
Zhenhua Hu, Xiao Xiao, Guiyun Zhang, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107032-107032
Open Access
Zhenhua Hu, Xiao Xiao, Guiyun Zhang, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107032-107032
Open Access
A Physiologically Relevant In Vitro Model of Nonreplicating Persistent Mycobacterium tuberculosis in Caseum
Min Xie, Paulina Osiecki, Sergio D. Rodríguez, et al.
Current Protocols (2025) Vol. 5, Iss. 3
Open Access
Min Xie, Paulina Osiecki, Sergio D. Rodríguez, et al.
Current Protocols (2025) Vol. 5, Iss. 3
Open Access
Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials
Yanan Niu, Junya Feng, Jie Ma, et al.
Exploration (2025)
Open Access
Yanan Niu, Junya Feng, Jie Ma, et al.
Exploration (2025)
Open Access
Nα‐Aroyl‐N‐Aryl‐Phenylalanine Amides: A Promising Class of Antimycobacterial Agents Targeting the RNA Polymerase
Rüdiger W. Seidel, Richard Goddard, Markus Lang, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Open Access | Times Cited: 2
Rüdiger W. Seidel, Richard Goddard, Markus Lang, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Open Access | Times Cited: 2
Characterizing the immune response to Mycobacterium tuberculosis: a comprehensive narrative review and implications in disease relapse
F Rahman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
F Rahman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Molecular and microbiological methods for the identification of nonreplicating Mycobacterium tuberculosis
Jansy P. Sarathy
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012595-e1012595
Open Access
Jansy P. Sarathy
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012595-e1012595
Open Access
Validation of DXS as an attractive drug target in mycobacteria
T Maila, M Nicolaai, Rendani Mbau, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
T Maila, M Nicolaai, Rendani Mbau, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
